Shopping Cart 0
Cart Subtotal
USD 0

University of Florida - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

University of Florida (UF) is an educational institute that offers undergraduate, graduate and distance learning programs. The institute offers educational programs in areas of agricultural, business administration, journalism and communications, law, dentistry, arts and sciences, medicine, nursing, engineering, pharmacy, fine arts and veterinary medicine, among others. It also offers advertising, marketing and public relations and human services, among others. The institute conducts research in brain related problems, aging problems, oncology, genetics, pathogens and gene therapy, among others. UF is headquartered in Gainesville, Florida, the US.

University of Florida-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

University of Florida, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

University of Florida, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

University of Florida, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

University of Florida, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

University of Florida, Medical Devices Deals, 2012 to YTD 2018 10

University of Florida, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

University of Florida, Pharmaceuticals & Healthcare, Deal Details 12

Venture Financing 12

Colorescience Raises USD 10 Million In Series A Financing 12

Partnerships 13

Prometheon Enters into Licensing Agreement with University of Florida Research Foundation 13

NeuroVive Pharma Enters into Collaboration Agreement with University of Florida 14

CRISPR Therapeutics to Enter into Agreement with University of Florid 15

Prosolia Enters into Research Agreement with University of Florida 16

Cloud Pharma Enters into Agreement with University of Florida Health 17

Genzyme Enters into Co-Development Agreement with University of Florida and University of Pennsylvania 18

IntelliCell BioSciences Enters Into Research Agreement With University of Florida For Stem Cell And Tissue Repair 19

Licensing Agreements 20

Ophthotech Enters into Licensing Agreement with University of Florida Research Foundation and the University of Pennsylvania 20

DNAtrix Enters into Licensing Agreement with University of Florida 21

Audentes Therapeutics Amends its Licensing Agreement with University of Florida Research Foundation 22

University of Florida-Key Competitors 23

University of Florida-Key Employees 24

University of Florida-Locations And Subsidiaries 25

Head Office 25

Other Locations & Subsidiaries 25

Recent Developments 26

Government and Public Interest 26

Sep 04, 2018: Using mathematical modeling to target infections 26

Jun 24, 2018: For invasive bladder cancer, removing whole bladder better than less invasive options 28

Feb 16, 2018: Common blood pressure drug may prevent type 1 diabetes 29

Feb 15, 2018: Existing drug effective at preventing onset of Type 1 diabetes 30

Oct 31, 2017: NIH establishes new research in social epigenomics to address health disparities 32

Sep 26, 2017: Study outlines precancerous treatment of anal lesions 35

Aug 29, 2017: Morehouse School of Medicine Joins the NIH All of Us Research Consortium 36

Aug 29, 2017: NIH's All of Us Research Program expands national network of medical centers 37

Jul 26, 2017: Waterlogged brain region helps scientists gauge damage caused by Parkinson's disease 38

May 08, 2017: BrightFocus Foundation Honors Five Researchers on Macular Degeneration and Glaucoma 39

Product News 40

May 01, 2018: Study of Oral Moisturizers Concludes Most US OTC Dry Mouth Products Contain Harmful Levels of Acidity that Cause Tooth Erosion 40

03/29/2018: USD 3.2 Million grant funds development of new malaria vaccine 41

Other Significant Developments 43

Aug 31, 2018: Novel concepts for the diagnosis of fatty liver and personalized treatment: a review and recommendations 43

Apr 02, 2018: UNC Releases Huge Database of Molecules to Support Artificial Intelligence Methods in Chemistry 44

Mar 28, 2018: As the GHIT Fund Closes Out First Five Years of R&D for Lifesaving Medical Breakthroughs, It Launches Next Phase, Focusing on Access and Delivery, Bringing Total Investment to 13.2 Billion Yen (USD 123 Million) 45

Appendix 48

Methodology 48

About GlobalData 48

Contact Us 48

Disclaimer 48


List Of Figure

List of Figures

University of Florida, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

University of Florida, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

University of Florida, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

University of Florida, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

University of Florida, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

University of Florida, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

University of Florida, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

University of Florida, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

University of Florida, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

University of Florida, Pharmaceuticals & Healthcare, Key Facts 2

University of Florida, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

University of Florida, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

University of Florida, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

University of Florida, Deals By Therapy Area, 2012 to YTD 2018 9

University of Florida, Medical Devices Deals, 2012 to YTD 2018 10

University of Florida, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Colorescience Raises USD 10 Million In Series A Financing 12

Prometheon Enters into Licensing Agreement with University of Florida Research Foundation 13

NeuroVive Pharma Enters into Collaboration Agreement with University of Florida 14

CRISPR Therapeutics to Enter into Agreement with University of Florid 15

Prosolia Enters into Research Agreement with University of Florida 16

Cloud Pharma Enters into Agreement with University of Florida Health 17

Genzyme Enters into Co-Development Agreement with University of Florida and University of Pennsylvania 18

IntelliCell BioSciences Enters Into Research Agreement With University of Florida For Stem Cell And Tissue Repair 19

Ophthotech Enters into Licensing Agreement with University of Florida Research Foundation and the University of Pennsylvania 20

DNAtrix Enters into Licensing Agreement with University of Florida 21

Audentes Therapeutics Amends its Licensing Agreement with University of Florida Research Foundation 22

University of Florida, Key Competitors 23

University of Florida, Key Employees 24

University of Florida, Subsidiaries 25

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

University of Florida, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

University of Florida (UF) is an educational institute that offers undergraduate, graduate and distance learning programs. The institute offers educational programs in areas of agricultural, business administration, journalism and communications, law, dentistry, arts and sciences, medicine, nursing, engineering, pharmacy, fine arts and veterinary medicine, among others. It also offers advertising, marketing and public relations and human services, among others. The institute conducts research in brain related problems, aging problems, oncology, genetics, pathogens and gene therapy, among others. UF is headquartered in Gainesville, Florida, the US.

University of Florida-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

University of Florida, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

University of Florida, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

University of Florida, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

University of Florida, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

University of Florida, Medical Devices Deals, 2012 to YTD 2018 10

University of Florida, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

University of Florida, Pharmaceuticals & Healthcare, Deal Details 12

Venture Financing 12

Colorescience Raises USD 10 Million In Series A Financing 12

Partnerships 13

Prometheon Enters into Licensing Agreement with University of Florida Research Foundation 13

NeuroVive Pharma Enters into Collaboration Agreement with University of Florida 14

CRISPR Therapeutics to Enter into Agreement with University of Florid 15

Prosolia Enters into Research Agreement with University of Florida 16

Cloud Pharma Enters into Agreement with University of Florida Health 17

Genzyme Enters into Co-Development Agreement with University of Florida and University of Pennsylvania 18

IntelliCell BioSciences Enters Into Research Agreement With University of Florida For Stem Cell And Tissue Repair 19

Licensing Agreements 20

Ophthotech Enters into Licensing Agreement with University of Florida Research Foundation and the University of Pennsylvania 20

DNAtrix Enters into Licensing Agreement with University of Florida 21

Audentes Therapeutics Amends its Licensing Agreement with University of Florida Research Foundation 22

University of Florida-Key Competitors 23

University of Florida-Key Employees 24

University of Florida-Locations And Subsidiaries 25

Head Office 25

Other Locations & Subsidiaries 25

Recent Developments 26

Government and Public Interest 26

Sep 04, 2018: Using mathematical modeling to target infections 26

Jun 24, 2018: For invasive bladder cancer, removing whole bladder better than less invasive options 28

Feb 16, 2018: Common blood pressure drug may prevent type 1 diabetes 29

Feb 15, 2018: Existing drug effective at preventing onset of Type 1 diabetes 30

Oct 31, 2017: NIH establishes new research in social epigenomics to address health disparities 32

Sep 26, 2017: Study outlines precancerous treatment of anal lesions 35

Aug 29, 2017: Morehouse School of Medicine Joins the NIH All of Us Research Consortium 36

Aug 29, 2017: NIH's All of Us Research Program expands national network of medical centers 37

Jul 26, 2017: Waterlogged brain region helps scientists gauge damage caused by Parkinson's disease 38

May 08, 2017: BrightFocus Foundation Honors Five Researchers on Macular Degeneration and Glaucoma 39

Product News 40

May 01, 2018: Study of Oral Moisturizers Concludes Most US OTC Dry Mouth Products Contain Harmful Levels of Acidity that Cause Tooth Erosion 40

03/29/2018: USD 3.2 Million grant funds development of new malaria vaccine 41

Other Significant Developments 43

Aug 31, 2018: Novel concepts for the diagnosis of fatty liver and personalized treatment: a review and recommendations 43

Apr 02, 2018: UNC Releases Huge Database of Molecules to Support Artificial Intelligence Methods in Chemistry 44

Mar 28, 2018: As the GHIT Fund Closes Out First Five Years of R&D for Lifesaving Medical Breakthroughs, It Launches Next Phase, Focusing on Access and Delivery, Bringing Total Investment to 13.2 Billion Yen (USD 123 Million) 45

Appendix 48

Methodology 48

About GlobalData 48

Contact Us 48

Disclaimer 48


List Of Figure

List of Figures

University of Florida, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

University of Florida, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

University of Florida, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

University of Florida, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

University of Florida, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

University of Florida, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

University of Florida, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

University of Florida, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

University of Florida, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

University of Florida, Pharmaceuticals & Healthcare, Key Facts 2

University of Florida, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

University of Florida, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

University of Florida, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

University of Florida, Deals By Therapy Area, 2012 to YTD 2018 9

University of Florida, Medical Devices Deals, 2012 to YTD 2018 10

University of Florida, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Colorescience Raises USD 10 Million In Series A Financing 12

Prometheon Enters into Licensing Agreement with University of Florida Research Foundation 13

NeuroVive Pharma Enters into Collaboration Agreement with University of Florida 14

CRISPR Therapeutics to Enter into Agreement with University of Florid 15

Prosolia Enters into Research Agreement with University of Florida 16

Cloud Pharma Enters into Agreement with University of Florida Health 17

Genzyme Enters into Co-Development Agreement with University of Florida and University of Pennsylvania 18

IntelliCell BioSciences Enters Into Research Agreement With University of Florida For Stem Cell And Tissue Repair 19

Ophthotech Enters into Licensing Agreement with University of Florida Research Foundation and the University of Pennsylvania 20

DNAtrix Enters into Licensing Agreement with University of Florida 21

Audentes Therapeutics Amends its Licensing Agreement with University of Florida Research Foundation 22

University of Florida, Key Competitors 23

University of Florida, Key Employees 24

University of Florida, Subsidiaries 25

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

University of Florida, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

chat_bubbleLet's Chat